Kenneth Myszkowski

Insider Reports History

Entity
Individual
Location
Arrowhead Research Corporation, 201 South Lake Avenue, Suite 703, Pasadena, CA
Signature
/s/Kenneth Myszkowski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Myszkowski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARROWHEAD PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 401K $14.1M $35.19 Mar 6, 2024 Direct

Insider Reports Filed by Kenneth Myszkowski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARWR ARROWHEAD PHARMACEUTICALS, INC. Mar 6, 2024 1 -$1.41M 4 Mar 8, 2024 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 4, 2024 4 -$568K 4 Jan 8, 2024 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jun 27, 2023 1 -$543K 4 Jun 29, 2023 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 4, 2023 1 $0 4 Jan 5, 2023 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Dec 29, 2022 1 -$1.23M 4 Dec 30, 2022 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Sep 30, 2022 1 $0 5 Sep 30, 2022 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 5, 2022 4 -$2.47M 4 Jan 6, 2022 Chief Financial Officer
ARWR ARROWHEAD PHARMACEUTICALS, INC. Jan 1, 2022 1 $0 4 Jan 4, 2022 Chief Financial Officer